Nosh.bio Launches Hybrid Beef Mince Containing Koji Protein Through Food Service Collaboration
Berlin-based fungi protein startup Nosh.bio is launching a hybrid beef mince and koji protein product in partnership with the food service sector. The product will initially be made available through a collaboration with Berlin restaurant Speisemanufaktur Adlershof, which will serve the hybrid mince across a variety of familiar dishes such as burgers, meatballs, and lasagna. These meals will be available to the public for a week; there will also be …
Nosh.bio: “The Next Major Leap for Alt-Proteins Will Come From Focusing on the Essentials”
Nosh.bio is a Berlin-based startup focused on developing sustainable, scalable protein solutions using koji-based fermentation. Founded in 2022, the company aims to help food manufacturers create affordable, nutritious, and environmentally friendly ingredients for plant-based and hybrid food products. Tim Fronzek, Co-Founder and CEO, has over 15 years of leadership experience. Prior to Nosh.bio, Tim co-founded reBuy.com, growing it to €200 million in net sales. After taking a break in 2020 …
Germany’s Leading Meat Processor Tönnies Group Invests in Mycoprotein Producer Nosh.bio
Giant slaughterhouse Tönnies Group, Germany’s leading meat processing company, has made a strategic investment (undisclosed) in the mycoprotein producer Nosh.bio. Co-owner and managing director Max Tönnies, who has assumed leadership from his father, the billionaire Clemens Tönnies, made the announcement yesterday, which the local media have extensively covered. Despite the stagnation of the plant-based meat market, Spiegel reported that the group aims to double its turnover in the alternative proteins sector …
Sponsored
Sponsored
Nosh.bio’s Retroffited Plant Ready to Produce “Thousands of Tons” of Mycoprotein Annually
Nosh.bio, a B2B biomass fermentation startup recently showcased on the Investment Climate Podcast, announces it has achieved a production milestone at its newly established plant near Dresden, Germany. The biotech explains that it has conducted extensive production trials, indicating that is on track to produce “thousands of tons” of its mycoprotein ingredient annually. The inaugural production run is expected to occur within the next four to five months. The company’s …
Investment Climate Podcast: Tim Fronzek of Nosh.bio Reveals the Secrets to Fundraising Success
In this new podcast series, co-produced by vegconomist, Alex Shandrovksy interviews investors about benchmarks for funding alt proteins in 2024 and uncovers the investment playbooks of successful Climate Tech CEOs and Leading VCs. Podcast Host Alex Shandrovksy is a strategic advisor to numerous global food tech accelerators and companies, including leaders in alternative proteins and cellular agriculture. His focus is on investor relations and post-raise scale for agrifood tech companies. …